Correlation of serum levels of HIF-1α and IL-19 with the disease progression of COPD: a retrospective study
Authors Rong B, Liu Y, Li M, Fu T, Gao W, Liu H
Received 12 June 2018
Accepted for publication 15 August 2018
Published 21 November 2018 Volume 2018:13 Pages 3791—3803
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Chunxue Bai
Biaoxue Rong,1 Yufang Liu,2 Min Li,3 Tian Fu,4 Wenlong Gao,5 Hua Liu6
1Department of Respiratory Medicine, First Affiliated Hospital, Xi’an Medical University, Xi’an, China; 2Comprehensive Medicine Department, Shenmu Hospital, Shenmu, China; 3Department of Respiratory Medicine, Shenmu Hospital, Shenmu, China; 4Department of Respiratory Medicine, Jining No 1 People’s Hospital, Jining, China; 5Institute of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, Lanzhou, China; 6Department of Respiratory Medicine, Gansu Provincial Hospital, Lanzhou, China
Background: The aim of this study was to disclose the correlation between the serum levels of hypoxia-inducible factor 1 alpha (HIF-1α) and IL-19 and stable COPD.
Methods: The serum levels of HIF-1α and IL-19 were tested by ELISA. The relationships between their levels and clinical parameters of stable COPD patients were analyzed by linear regression methods.
Results: Patients with stable COPD showed higher serum levels of HIF-1α and IL-19 compared with healthy control group (P<0.001), and serum levels of HIF-1α and IL-19 had a positive linear correlation (P<0.05). In stable COPD patients, increased serum levels of HIF-1α and IL-19 were positively correlated with the GOLD grading (P<0.005), modified British Medical Research Council (mMRC) score (P<0.05), and medical history (P<0.05) but negatively related to the pulmonary function (P<0.05). The serum level of HIF-1α (P<0.05) was affected by the patient’s FEV1/FVC value and COPD grading, and the serum level of IL-19 was associated with the mMRC scores and the serum level of HIF-1α (P<0.05).
Conclusion: Increased serum levels of HIF-1α and IL-19 correlated with the disease progression of COPD, suggesting that they can be used as indicators to help us understand the COPD.
Keywords: chronic obstructive pulmonary disease, COPD, hypoxia-inducible factor 1 alpha, interleukin-19, serum, pulmonary function
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]